SEARCH

SEARCH BY CITATION

References

  • 1
    Lelbach WK. Liver damage in chronic alcoholism: results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low calorie diet in an open drinking sanatorium. Acta Hepatosplenol 1966; 13: 321349.
  • 2
    Tsukamoto H, Reiderberger RD, French SW, Largman C. Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol 1984; 247: R595R599.
  • 3
    French SW, Miyamoto K, Tsukamoto H. Ethanol-induced hepatic fibro-sis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res 1986; 10: 13S19S.
  • 4
    Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. Methods Enzymol 1994; 233: 585594.
  • 5
    Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994; 20: 453460.
  • 6
    Knecht KT, Adachi Y, Bradford BU, Limuro Y, Kadiiska M, Qun-hui X, Thurman RG. Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells. Mol Pharmacol 1995; 47: 10281034.
  • 7
    Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108: 218224.
  • 8
    Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990; 10: 293304.
  • 9
    McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349351.
  • 10
    Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor α predicts decreased long term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255259.
  • 11
    McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM. Serum interleukin 1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986; 3: 14791485.
  • 12
    Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992; 119: 547552.
  • 13
    Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin-lα, tumor necrosis factor and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989; 9: 7178.
  • 14
    Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995; 21: 13041309.
  • 15
    Nanji A, Zhao S, Sadrzadeh SMH, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994; 19: 14831487.
  • 16
    Windmer U, Manougue KR, Cerami A, Sherry B. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-lα, and MIP-1β, members of the chemokine superfamily of proinflammatory cytokines. J Immunol 1993; 150: 49965012.
  • 17
    Driscoll KE, Hassenbein DG, Howard BW, Isfort RJ, Cody D, Tindal MH, Suchanek M, et al. Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J Leukoc Biol 1995; 58: 359364.
  • 18
    Kayama F, Yoshida T, Elwell MR, Luster MI. Role of tumor necrosis factor-a in cadmium-induced hepatotoxicity. Toxicol Appl Pharmacol 1995:; 131: 224234.
  • 19
    Thompson JA, Reitz RC. Effects of ethanol ingestion and dietary fat levels on mitochondrial lipids in male and female rats. Lipid 1978; 13: 540550.
  • 20
    Roitt I. The acquired immune response. In: RoittI, ed. Essential immunology. Oxford: Blackwell, 1988: 142: 105223.
  • 21
    Badger TM, Crouch J, Irby D, Shahare M. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions. J Pharmacol Exp Therapeut 1993; 264: 938943.
  • 22
    Kloppel G, Maillet B. Chronic pancreatitis: evolution of the disease. Hepatogastroenterology 1991; 38: 408412.
  • 23
    Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989; 13: 1519.
  • 24
    Tsukamoto H, French SW, Reidelberger RD, Largman C. Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res 1985; 9: 3137.
  • 25
    Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 245247.
  • 26
    Bruccoleri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, Thurman RG, Luster MI. Induction of early-immediate genes by tumor necrosis factor α contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 1997; 25: 133141.
  • 27
    Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263: G579G585.
  • 28
    Hinshaw LB, Emerson TE Jr., Chang AC, Duerr M, Peer G, Fournel M. Study of septic shock in the non-human primate: Relationship of pathophysiological response to therapy with anti-TNF antibody. Circ Shock 1994; 44: 221229.
  • 29
    Nakagawa J, Hishinuma I, Hirota K, Miyamoto K, Yamanaka T, Tsuki-date K, Katayama K, et al. Involvement of tumor necrosis factor α in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1991; 100: 11531154.
  • 30
    Hishinuma I, Nakagawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, Katayama K, et al. Tumor necrosis factor-α in development of hepatic injury in galactosamine-sensitized mice. Hepatology 1990; 12: 11871191.
  • 31
    Casteleijn E, Kuiper J, Van Rooij HCJ, Kamps JAAM, Koster JF, Van Berkel TJC. Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem 1988; 263: 26992703.
  • 32
    Bode JC, Bode C, Heidelbach R, Durr H-K, Martini GA. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984; 31: 3034.
  • 33
    Bode JC. Alcohol and the gastrointestinal tract. In: FrickHP, HarnackGA, MartiniGA, PraderA, eds. Advances in internal medicine and pediatrics. Heidelberg: Springer-Verlag, 1980: 175.
  • 34
    Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; 1: 179182.
  • 35
    Robinson GM, Orrego H, Israel Y, Devenyi P, Kapur BM. Low-molecular weight polyethylene glycol as a probe of gastrointestinal permeability after alcohol ingestion. Dig Dis Sci 1981; 26: 971977.
  • 36
    Arai M. Effect of ethanol on the intestinal uptake of endotoxin [Abstract]. Nippon Shokakibyo Gakkai Zasshi 1986; 83: 1060.
  • 37
    Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 1993; 142: 367373.
  • 38
    Nanji AA, Khettry U, Sadrzadeh SMH. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 1994; 205: 243247.
  • 39
    Bradford BU, Misra UK, Thurman RG. Kupffer cells are required for the swift increase in alcohol metabolism. Res Commun Subst Abuse 1993; 14: 16.
  • 40
    Qu W, Zhong Z, Goto M, Thurman RG. Kupffer cell prostaglandin E2 stimulates parenchymal cell O2 consumption: alcohol and cell-cell communication. Am J Physiol 1996; 270: G574G580.
  • 41
    Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Physiol 1989; 135: 121133.
  • 42
    Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 92389242.
  • 43
    Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107: 321331.
  • 44
    Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdroph AM. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 44204425.
  • 45
    Philip R, Epstein LB. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, y-interferon and interleukin 1. Nature 1986; 3 23: 8689.
  • 46
    Ming WJ, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987; 138: 14691474.
  • 47
    Djeu JY, Blanchard DK, Halkias D, Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by inter-feron-γ and tumor necrosis factor. J Immunol 1986; 137: 29802984.
  • 48
    Shalaby MR, Aggarwal BB, Rinderknecht E, Sevedersky LP, Finkle BS, Palladino MA, Jr. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factor. J Immunol 1985; 135: 20692073.
  • 49
    Tsujimoto M, Yokota S, Vilcek J, Weismann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Bio-phys Res Commun 1986; 137: 10941100.
  • 50
    Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994; 20: 473490.
  • 51
    Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, Standiford TJ. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996; 173: 159165.
  • 52
    Yodlowski ML, Hubbard JR, Kispert J, Keller K, Sledge CB, Steinberg JJ. Antibody to interleukin 1 inhibits the cartilage degradative and thy-mocyte proliferative actions of rheumatoid synovial culture medium. J Rheumatol 1990; 17: 1600607.
  • 53
    Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogeneous interleukin-1 rabbit immune colitis. Gastroenterology 1992; 103: 6571.